Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sadahiro Naka

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Clinical Nuclear Medicine|September 24, 2020
18F-FBPA PET in Sarcoidosis: Comparison to Inflammation-Related Uptake on FDG PETTadashi Watabe, Hiroaki Shimamoto, Sadahiro Naka, et al.
Annals of Nuclear Medicine|September 3, 2016
Assessment of <sup>10</sup>B concentration in boron neutron capture therapy: potential of image-guided therapy using <sup>18</sup>FBPA PETEku Shimosegawa, Kayako Isohashi, Sadahiro Naka, et al.
Annals of Nuclear Medicine|November 9, 2010
Evaluation of radioiodinated quinazoline derivative as a new ligand for EGF receptor tyrosine kinase activity using SPECTMasahiko Hirata, Yasukazu Kanai, Sadahiro Naka, et al.
EJNMMI Physics|January 12, 2021
Individual dosimetry system for targeted alpha therapy based on PHITS coupled with microdosimetric kinetic modelTatsuhiko Sato, Takuya Furuta, Yuwei Liu, et al.
Diagnostics (Basel, Switzerland)|August 7, 2021
Evaluation of Integrin α<sub>v</sub>β<sub>3</sub> Expression in Murine Xenograft Models: [<sup>68</sup>Ga]Ga-DOTA-C(RGDfK) PET Study with Immunohistochemical ConfirmationKosuke Mitsuyuki, Tadashi Watabe, Sadahiro Naka, et al.
Annals of Nuclear Medicine|February 23, 2012
Synthesis and evaluation of radioiodinated phenoxyquinazoline and benzylaminoquinazoline derivatives as new EGF receptor tyrosine kinase imaging ligands for tumor diagnosis using SPECTMasahiko Hirata, Yasukazu Kanai, Sadahiro Naka, et al.
Nuclear Medicine and Molecular Imaging|April 22, 2022
Improved Stability and Practicality for Synthesis of 4-Borono-2-[<sup>18</sup>F]fluoro-l-phenylalanine by Combination of [<sup>18</sup>O]O<sub>2</sub> Single-Use and [<sup>18</sup>F]CH<sub>3</sub>COOF Labeling AgentsSadahiro Naka, Toshimitsu Watanabe, Yasukazu Kanai, et al.
EJNMMI Research|April 17, 2013
Optimization of [11C]methionine PET study: appropriate scan timing and effect of plasma amino acid concentrations on the SUVKayako Isohashi, Eku Shimosegawa, Hiroki Kato, et al.
Biological & Pharmaceutical Bulletin|March 4, 2014
Monitoring of gefitinib sensitivity with radioiodinated PHY based on EGFR expressionMitsuyoshi Yoshimoto, Masahiko Hirata, Yasukazu Kanai, et al.
Seminars in Nuclear Medicine|October 1, 2025
Development of PSMA-Targeted Alpha Therapy Using [<sup>211</sup>At]PSMA-5Tadashi Watabe, Sadahiro Naka, Yoshifumi Shirakami, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Clinical Nuclear Medicine|September 24, 2020
18F-FBPA PET in Sarcoidosis: Comparison to Inflammation-Related Uptake on FDG PETTadashi Watabe, Hiroaki Shimamoto, Sadahiro Naka, et al.
Annals of Nuclear Medicine|September 3, 2016
Assessment of <sup>10</sup>B concentration in boron neutron capture therapy: potential of image-guided therapy using <sup>18</sup>FBPA PETEku Shimosegawa, Kayako Isohashi, Sadahiro Naka, et al.
Annals of Nuclear Medicine|November 9, 2010
Evaluation of radioiodinated quinazoline derivative as a new ligand for EGF receptor tyrosine kinase activity using SPECTMasahiko Hirata, Yasukazu Kanai, Sadahiro Naka, et al.
EJNMMI Physics|January 12, 2021
Individual dosimetry system for targeted alpha therapy based on PHITS coupled with microdosimetric kinetic modelTatsuhiko Sato, Takuya Furuta, Yuwei Liu, et al.
Diagnostics (Basel, Switzerland)|August 7, 2021
Evaluation of Integrin α<sub>v</sub>β<sub>3</sub> Expression in Murine Xenograft Models: [<sup>68</sup>Ga]Ga-DOTA-C(RGDfK) PET Study with Immunohistochemical ConfirmationKosuke Mitsuyuki, Tadashi Watabe, Sadahiro Naka, et al.
Annals of Nuclear Medicine|February 23, 2012
Synthesis and evaluation of radioiodinated phenoxyquinazoline and benzylaminoquinazoline derivatives as new EGF receptor tyrosine kinase imaging ligands for tumor diagnosis using SPECTMasahiko Hirata, Yasukazu Kanai, Sadahiro Naka, et al.
Nuclear Medicine and Molecular Imaging|April 22, 2022
Improved Stability and Practicality for Synthesis of 4-Borono-2-[<sup>18</sup>F]fluoro-l-phenylalanine by Combination of [<sup>18</sup>O]O<sub>2</sub> Single-Use and [<sup>18</sup>F]CH<sub>3</sub>COOF Labeling AgentsSadahiro Naka, Toshimitsu Watanabe, Yasukazu Kanai, et al.
EJNMMI Research|April 17, 2013
Optimization of [11C]methionine PET study: appropriate scan timing and effect of plasma amino acid concentrations on the SUVKayako Isohashi, Eku Shimosegawa, Hiroki Kato, et al.
Biological & Pharmaceutical Bulletin|March 4, 2014
Monitoring of gefitinib sensitivity with radioiodinated PHY based on EGFR expressionMitsuyoshi Yoshimoto, Masahiko Hirata, Yasukazu Kanai, et al.
Seminars in Nuclear Medicine|October 1, 2025
Development of PSMA-Targeted Alpha Therapy Using [<sup>211</sup>At]PSMA-5Tadashi Watabe, Sadahiro Naka, Yoshifumi Shirakami, et al.
Pageof 5